Why A2 Milk shares and this mid cap ASX share could be buys

The broker has could things to say about these shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are a lot of ASX shares out there for investors to choose from, but two that come highly rated by analysts at Macquarie Group Ltd (ASX: MQG) are named below.

Here's why the broker is bullish on these names and tipping them as buys in March.

A woman presenting company news to investors looks back at the camera and smiles.

Image source: Getty Images

A2 Milk Company Ltd (ASX: A2M)

Infant formula company A2 Milk gets the thumbs up from Macquarie. It remains positive on A2 Milk shares despite its price target being largely in line with its current share price.

This is because the broker believes there are potential catalysts on the horizon that could drive a meaningful re-rating of the infant formula company's shares in the near future. It explains:

While A2M has re-rated strongly post-result and on China-stimulus news, key catalysts will be further earnings upgrades, success of recent product innovation, capital management, and supply-chain investment increasing China market access.

Its analysts currently have an outperform rating and $7.85 price target on the company's shares.

GQG Partners Inc (ASX: GQG)

As well as A2 Milk shares, Macquarie is tipping investment company GQG Partners as one to buy this month.

The broker highlights that GQG Partners' four investment strategies have been narrowed down from thousands of potential strategies. This helps explain how the company continues to perform so positively. It said:

At the 1H25 result GQG provided an overview of performance. The hurdles were set by GQG. GQG screened: #1) 6,641 strategies; #2) compared the 62% with a 10yrplus track record; #3) cut the list down to the 1.72% with positive excess return in 100% of 5-yr rolling periods, on a 1-mth shift; #4) looked for low volatility, beta <=0.8 vs benchmark; and #5) combined with downside risk management, measured by positive excess return in each major downturn period, MSCI ACWI Net Index declined by 10%+, over the prior decade (3Q2015 energy, 4Q2018 China, 1Q2020 COVID, and 1Q2022-3Q2022 Russia and rates). While the hurdles were set by GQG, only 4 strategies remained, or 0.06% of the total. All 4 were GQG primary strategies.

Unlike A2 Milk shares, Macquarie sees significant potential returns from where GQG Partners trades today. Its analysts have an outperform rating and $3.00 price target on the investment company's shares. This suggests that upside of 35% is possible from current levels.

The broker is also expecting a huge 10% dividend yield over the next 12 months, boosting the total potential return to approximately 45%.

Motley Fool contributor James Mickleboro has positions in Gqg Partners. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended A2 Milk and Gqg Partners. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a miner holds his thumb up as he holds a device in his other hand.
Resources Shares

Experts name 3 ASX mining shares to buy after March sell-off

Investors took profits amid fears the fuel crisis could impact miners' production and earnings.

Read more »